Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Biopsy Sciences, LLC — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

91 daysmedian FDA review time
136 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K130537BIOPSY SCIENCES LLC HYDROMARK BREAST BIOPSY SITE MARKERBiopsy Sciences, LLC2013-03-29280
K121113BIOPSY SCIENCES, INC. HYDROMARK BREST BIOSY SITE MARKERBiopsy Sciences, LLC2012-07-12910
K090501BIOPSY SCIENCES HYDROMARK BREAST BIOPSY SITE MARKER, MODELS Biopsy Sciences, LLC2009-03-0580
K083006BIOPSY SCIENCES, INC., HYDROMARK BREAST BIOPSY SITE MARKERBiopsy Sciences, LLC2009-02-091240
K060769HYDROMARK BIOPSY SITE MARKERBiopsy Sciences, LLC2006-07-251250
K041331BIOPSY SCIENCES, LLC, LUNG BIOPSY SITE MARKERBiopsy Sciences, LLC2004-06-15270
K023694BIO-MARK RESORBABLE BIOPSY SITE MARKER AND BIO-MARK PERMANENBiopsy Sciences, LLC2003-03-171360
K021847BIOPSY SCIENCES, LLC. MAXI-CELL BIOPSY NEEDLESBiopsy Sciences, LLC2002-09-03900

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda